Gregory Lambrecht
Fondatore presso Intrinsic Therapeutics, Inc.
Posizioni attive di Gregory Lambrecht
Società | Posizione | Inizio | Fine |
---|---|---|---|
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Direttore/Membro del Consiglio | 01/01/1999 | - |
Fondatore | 01/01/1999 | - | |
Coravin, Inc.
Coravin, Inc. Beverages: AlcoholicConsumer Non-Durables Coravin, Inc. develops new technology for tapping bottles of wine. Its system allows users to access and pour their favorite wines by the glass without pulling the cork. The firm offers wine access needles, triggers, capsules, clamps, needle assortment kits, carry cases, vintage needles, faster pour needles, standard replacement needles, wine bottle sleeve on bottles, and replacement base products. The company was founded by Greg Lambrecht and Josh Makower in 2011 and is headquartered in Burlington, MA. | Presidente | - | - |
Fondatore | - | - |
Storia della carriera di Gregory Lambrecht
Precedenti posizioni note di Gregory Lambrecht
Società | Posizione | Inizio | Fine |
---|---|---|---|
Viacor, Inc.
Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Direttore/Membro del Consiglio | - | 04/04/2012 |
Fondatore | 21/01/2010 | 04/04/2012 | |
PFIZER, INC. | Corporate Officer/Principal | - | - |
STRYKER CORPORATION | Vendite & Marketing | - | - |
Formazione di Gregory Lambrecht
Massachusetts Institute of Technology | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Posizioni
Founder | 3 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Settori
Health Technology | 5 |
Finance | 2 |
Consumer Non-Durables | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
PFIZER, INC. | Health Technology |
Aziende private | 3 |
---|---|
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Health Technology |
Viacor, Inc.
Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Health Technology |
Coravin, Inc.
Coravin, Inc. Beverages: AlcoholicConsumer Non-Durables Coravin, Inc. develops new technology for tapping bottles of wine. Its system allows users to access and pour their favorite wines by the glass without pulling the cork. The firm offers wine access needles, triggers, capsules, clamps, needle assortment kits, carry cases, vintage needles, faster pour needles, standard replacement needles, wine bottle sleeve on bottles, and replacement base products. The company was founded by Greg Lambrecht and Josh Makower in 2011 and is headquartered in Burlington, MA. | Consumer Non-Durables |
- Borsa valori
- Insiders
- Gregory Lambrecht
- Esperienza